Combination cyclopentolate and phenylephrine for mydriasis in premature infants with heavily pigmented irides

Journal of Pediatric Ophthalmology and Strabismus

Volumn 37, Issue 1, 2000, Pages 15-20

  Khoo, Boo Kian ^a,b   Koh, Adrian ^a   Cheong, Pauline ^a   Ho, Nai Kiong ^a  

^a KK WOMEN'S AND CHILDREN'S HOSPITAL   (Singapore)

^b TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPENTOLATE; PHENYLEPHRINE; TROPICAMIDE;

ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; LOW BIRTH WEIGHT; MYDRIASIS; PULSE RATE; RETROLENTAL FIBROPLASIA; SEIZURE;

CYCLOPENTOLATE; DIAGNOSIS, DIFFERENTIAL; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; EYE COLOR; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INTENSIVE CARE UNITS, NEONATAL; IRIS; MALE; MYDRIATICS; OPHTHALMIC SOLUTIONS; PHENYLEPHRINE; PROSPECTIVE STUDIES; PUPIL; RETINOPATHY OF PREMATURITY; SAFETY; TROPICAMIDE;

EID: 0034009283     PISSN: 01913913     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Awan KJ. Adverse systemic reactions of topical cyclopentolate hydrochloride. Ann Ophthalmol. 1976;8:695-698.
2. Kennerdell JS, Wucher FP. Cyclopentolate associated with two cases of grand mal seizure. Arch Ophthalmol. 1972,87:634-635.
3. Binkhorst RD, Weinstein GW, Baretz RM, et al. Psychotic reaction induced by cyclopentolate (Cyclogyl). Am J Ophthalmol. 1963;55:1234-1245.
4. Beswick JA. Psychosis from cyclopentolate. Am J Ophthalmol. 1962;53:879-880.
5. Simcoe CW. Cyclopentolate (Cyclogyl) toxicity; report of a case. Arch Ophthalmol. 1962;67:406-408.
6. Isenberg SJ, Abrams C, Hyman PE. Effects of cyclopentolate eyedrops on gastric secretory function in pre-term infants. Ophthalmology. 1985;92:698-700.
7. Lees BJ, Cabal LA. Increased blood pressure following pupillary dilation with 2.5% phenylephrine hydrochloride in preterm infants. Pediatrics. 1981;68:231-234.
8. Palmer EA. How safe are ocular drugs in pediatrics? Ophthalmology. 1986;93:1038-1040.
9. Resales T, Isenberg S, Leake R, Everett S. Systemic effects of mydriatics in low weight infants. J Pediatr Ophthalmol Strabismus. 1981;18:42-44.
10. Armstrong D, Norman MC. Periventricular leucomalacia in neonates. Complications and sequelae. Arch Dis Child. 1974;49:367-375.
11. Anonymous. Iris pigmentation and mydriatics. Br Med J. 1965; 13(5471):1139-1140.
12. Carpel EF, Kalina RE. Pupillary responses to mydriatic agents in premature infants. Am J Ophthalmol. 1973;75:988-991.
13. Fleck BW, Dhillon B, Mitchell A. Additive mydriatic effect of 2.5% phenylephrine and 0.5% tropicamide eyedrops in premature babies. J Pediatr Ophthalmol Strabismus. 1994;31:130-131.
14. Bolt B, Benz B, Koerner F, Bossi E. A mydriatic eye-drop combination without systemic effects for premature infants: a prospective double blind study. J Pediatr Ophthalmol Strabismus. 1992;29:157-162.
15. Merrit JC, Kraybill EN. Effects of mydriatics on blood pressure in premature infants. J Pediatr Ophthalmol Strabismus. 1982;18:42-46.
16. Sindel BD, Baker MD, Maisels MJ, Weinstein J. A comparison of die papillary and cardiovascular effects of various mydriatic agents in preterm infants. J Pediatr Ophthalmol Strabismus. 1986;23:273-276.
17. Isenberg S, Everett S, Parelhoff E. A comparison of mydriatic eye-drops in low-weight infants. Ophthalmology. 1984;91:278-279.
18. Caputo AR, Schnitzer RE. Systemic response to mydriatic eyedrops in neonates: mydriatics in neonates. J Pediatr Ophthalmol Strabismus. 1978;15:109-122.